Last updated on February 2018

Comparison of Aerosol Infasurf to Usual Care for Respiratory Distress Syndrome (RDS)


Brief description of study

For newborn infants born with a deficiency in lung surfactant because of prematurity or other causes of delayed lung maturation, lung surfactant replacement therapy is life saving. The objective of this trial is to demonstrate that there is a group of patients who can benefit from surfactant replacement therapy with lower risk of administration complications and less discomfort by utilizing an alternative, safer administration technique – aerosolization. 

Clinical Study Identifier: TX155612

Contact Investigators or Research Sites near you

Start Over

Columbus Regional Research Institute

IACT Health
Columbus, GA United States
  Connect »